Mucormycosis in post-COVID-19 renal transplant patients: A lethal complication in follow-up.
作者信息
Meshram Hari S, Kute Vivek B, Chauhan Sanshriti, Desai Sudeep
机构信息
Department of Nephrology and Transplantation, IKDRC-ITS, Ahmedabad, India.
出版信息
Transpl Infect Dis. 2021 Aug;23(4):e13663. doi: 10.1111/tid.13663. Epub 2021 Jun 16.
Abstract
摘要
相似文献
1
Mucormycosis in post-COVID-19 renal transplant patients: A lethal complication in follow-up.新型冠状病毒肺炎后肾移植患者的毛霉病：随访中的致命并发症
Transpl Infect Dis. 2021 Aug;23(4):e13663. doi: 10.1111/tid.13663. Epub 2021 Jun 16.
2
Mucormycosis associated with COVID-19 in two kidney transplant patients.两例 COVID-19 相关肾移植术后毛霉菌病。
Transpl Infect Dis. 2021 Aug;23(4):e13652. doi: 10.1111/tid.13652. Epub 2021 Jun 13.
3
Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.COVID 相关毛霉病在肾移植受者中的危险因素和结局。
Transpl Infect Dis. 2022 Apr;24(2):e13777. doi: 10.1111/tid.13777. Epub 2022 Jan 31.
4
Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.肾移植受者继发于 SARS-CoV2 的毛霉菌病：来自印度的单中心经验。
Int Urol Nephrol. 2022 Jul;54(7):1693-1703. doi: 10.1007/s11255-021-03057-5. Epub 2021 Nov 18.
5
COVID-19-Related Rhino-Orbital-Cerebral Mucormycosis in a Renal Transplant Recipient.COVID-19 相关肾移植受者的鼻眶脑毛霉病。
Exp Clin Transplant. 2022 Feb;20(2):213-217. doi: 10.6002/ect.2021.0317. Epub 2022 Jan 3.
6
Coronavirus Disease 2019-associated mucormycosis and cytomegalovirus coinfection in a kidney transplant recipient.一名肾移植受者的2019冠状病毒病相关毛霉菌病和巨细胞病毒合并感染
Saudi J Kidney Dis Transpl. 2021 Sep-Oct;32(5):1501-1504. doi: 10.4103/1319-2442.344779.
7
Mucormycosis in COVID-19 recovered patients.新冠康复患者中的毛霉菌病
J Med Virol. 2022 Apr;94(4):1272-1273. doi: 10.1002/jmv.27522. Epub 2021 Dec 18.
8
Rhino-Orbital-Cerebral Mucormycosis-Another Deadly Complication of COVID-19 Infection.鼻眶脑型毛霉菌病——新型冠状病毒肺炎感染的另一致命并发症
JAMA Ophthalmol. 2022 Jan 1;140(1):73-74. doi: 10.1001/jamaophthalmol.2021.5202.
9
Dental surveillance for Post-COVID mucormycosis.新冠后毛霉菌病的牙科监测
Indian J Dent Res. 2021 Jan-Feb;32(1):2. doi: 10.4103/ijdr.ijdr_594_21.
10
Isolated renal allograft arterial mucormycosis: an extremely rare complication.孤立性同种异体肾移植动脉毛霉菌病：一种极其罕见的并发症。
Nephrol Dial Transplant. 2003 May;18(5):1034-5. doi: 10.1093/ndt/gfg086.
引用本文的文献
1
Genome-Wide Exploration of Thiamin Pyrophosphate Riboswitches in Medically Relevant Fungi Reveals Diverse Distribution and Implications for Antimicrobial Drug Targeting.医学相关真菌中硫胺素焦磷酸核糖开关的全基因组探索揭示了其多样分布及对抗菌药物靶向的意义。
ACS Omega. 2024 Dec 10;9(51):50134-50146. doi: 10.1021/acsomega.4c00158. eCollection 2024 Dec 24.
2
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases.实体器官移植受者毛霉菌病的流行病学、临床表现及转归：病例报告的系统评价
Open Forum Infect Dis. 2024 Jan 30;11(6):ofae043. doi: 10.1093/ofid/ofae043. eCollection 2024 Jun.
3
Post COVID-19 mucormycosis in liver transplant recipients-Walking on a tight rope.肝移植受者的新冠后毛霉菌病——如履薄冰。
J Liver Transpl. 2021 Jul-Sep;3:100033. doi: 10.1016/j.liver.2021.100033. Epub 2021 Jul 27.
4
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review.《COVID-19 大流行期间的毛霉菌病及其激增：最新综述》。
Curr Microbiol. 2023 Aug 17;80(10):322. doi: 10.1007/s00284-023-03430-w.
5
A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?对 COVID-19 患者毛霉病病例的系统评价：它是 COVID-19、糖尿病和皮质类固醇的“邪恶三联征”吗？
J Family Med Prim Care. 2022 Jun;11(6):2573-2580. doi: 10.4103/jfmpc.jfmpc_1934_21. Epub 2022 Jun 30.
6
Onset of Mucormycosis in Patients with COVID-19: A Systematic Review on Patients' Characteristics.2019冠状病毒病患者毛霉病的发病情况：关于患者特征的系统评价
Eur J Dent. 2023 Feb;17(1):24-38. doi: 10.1055/s-0042-1751003. Epub 2022 Sep 1.
7
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）免疫抑制及用于治疗2019冠状病毒病（COVID-19）的疗法在机会性真菌感染发生中的作用：综述
Curr Res Biotechnol. 2022;4:337-349. doi: 10.1016/j.crbiot.2022.08.001. Epub 2022 Aug 3.
8
Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.COVID-19 相关毛霉病的流行病学、临床表现和治疗：来自印度西部浦那的单中心经验。
Mycoses. 2022 May;65(5):526-540. doi: 10.1111/myc.13435. Epub 2022 Mar 10.
9
COVID-19-associated mucormycosis of head-and-neck region: A systematic review.头颈部区域与新型冠状病毒肺炎相关的毛霉菌病：一项系统综述
J Clin Transl Res. 2022 Jan 3;8(1):31-42. eCollection 2022 Feb 25.
10
Mucormycosis in COVID-19: A systematic review of literature.2019冠状病毒病中的毛霉病：文献系统评价
Infez Med. 2021 Dec 10;29(4):504-512. doi: 10.53854/liim-2904-2. eCollection 2021.
本文引用的文献
1
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
2
Mucormycosis associated with COVID-19 in two kidney transplant patients.两例 COVID-19 相关肾移植术后毛霉菌病。
Transpl Infect Dis. 2021 Aug;23(4):e13652. doi: 10.1111/tid.13652. Epub 2021 Jun 13.
3
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.COVID-19 感染后心脏移植受者发生毛霉菌病 - 病例报告及文献复习。
J Mycol Med. 2021 Jun;31(2):101125. doi: 10.1016/j.mycmed.2021.101125. Epub 2021 Apr 2.
4
Mucormycosis in renal transplant recipients: predictors and outcome.肾移植受者的毛霉菌病：预测因素与预后
Saudi J Kidney Dis Transpl. 2011 Jul;22(4):751-6.
Zotero 插件